Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-CDC37 Antibody (R3U35)

Catalog #:   RHH28505 Specific References (26) DATASHEET
Host species: Mouse
Isotype: IgG2a
Applications: ELISA, FCM, WB
Accession: Q16543
Overview

Catalog No.

RHH28505

Species reactivity

Human, Mouse

Host species

Mouse

Isotype

IgG2a

Clonality

Monoclonal

Applications

ELISA, FCM, WB

Recommended Dilution

Application Dilution
ELISA 1:10000, FCM: 1:200-1:400, WB: 1:500-1:2000

Target

CDC37, Hsp90 co-chaperone Cdc37, Hsp90 chaperone protein kinase-targeting subunit, p50Cdc37, CDC37A

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q16543

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3U35

Note

For research use only.

Data Image
  • Flow Cytometry
    Flow cytometric analysis of K562 cells using CDC37 mouse mAb (green) and negative control (red).
  • Western blot
    Western blot analysis using CDC37 mouse mAb against K562 (1), LNcap (2), A431 (3), HEK293 (4), and C2C12 (5) cell lysate.
References

A novel glycosaminoglycan-binding protein is the vertebrate homologue of the cell cycle control protein, Cdc37., PMID:7608185

A 50 kilodalton protein associated with raf and pp60(v-src) protein kinases is a mammalian homolog of the cell cycle control protein cdc37., PMID:9132011

p50(cdc37) is a nonexclusive Hsp90 cohort which participates intimately in Hsp90-mediated folding of immature kinase molecules., PMID:10858314

Molecular characterization of a novel intracellular hyaluronan-binding protein., PMID:10887182

Interaction of Hsp90 with the nascent form of the mutant epidermal growth factor receptor EGFRvIII., PMID:12471035

Identification of transcription coactivator OCA-B-dependent genes involved in antigen-dependent B cell differentiation by cDNA array analyses., PMID:12857960

Effect of single wall carbon nanotubes on human HEK293 cells., PMID:15585362

The platelet-derived growth factor receptor alpha is destabilized by geldanamycins in cancer cells., PMID:17079230

Analysis of the CK2-dependent phosphorylation of serine 13 in Cdc37 using a phospho-specific antibody and phospho-affinity gel electrophoresis., PMID:17922836

Evaluating CK2 activity with the antibody specific for the CK2-phosphorylated form of a kinase-targeting cochaperone Cdc37., PMID:18566753

Hsp90-dependent activation of protein kinases is regulated by chaperone-targeted dephosphorylation of Cdc37., PMID:18922470

Split Renilla luciferase protein fragment-assisted complementation (SRL-PFAC) to characterize Hsp90-Cdc37 complex and identify critical residues in protein/protein interactions., PMID:20413594

Constitutively active Lck kinase in T cells drives antigen receptor signal transduction., PMID:20541955

Serum IgG responses against Aspergillus proteins before hematopoietic stem cell transplantation or chemotherapy identify patients who develop invasive aspergillosis., PMID:22824184

Cell surface Cdc37 participates in extracellular HSP90 mediated cancer cell invasion., PMID:22912728

Hsp90, an unlikely ally in the war on cancer., PMID:23356585

IP-FCM platform detects the existence and regulator-caused dissociation of components in naturally assembled HSP90 complex., PMID:24265268

Protein kinase CK2 inhibition is associated with the destabilization of HIF-1α in human cancer cells., PMID:25449433

Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia., PMID:26397138

Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme., PMID:27825958

Ganetespib for small cell lung cancer., PMID:27922280

DCZ3112, a novel Hsp90 inhibitor, exerts potent antitumor activity against HER2-positive breast cancer through disruption of Hsp90-Cdc37 interaction., PMID:30017966

SUMOylation Is Required for ERK5 Nuclear Translocation and ERK5-Mediated Cancer Cell Proliferation., PMID:32209980

Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway., PMID:33412308

Phosphatases maintain low catalytic activity of SGK1: DNA damage resets the balance in favor of phosphorylation., PMID:37343701

Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer., PMID:38359495

Datasheet

Document Download

Anti-CDC37 Antibody (R3U35).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-CDC37 Antibody (R3U35) [RHH28505]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2026 AntibodySystem All Rights Reserved.            All Products are for Research Use Only